Contents

Veeva Systems considers the benefits and drawbacks of messaging services for
HCPs as well as explaining Veeva's own platform, which combats these issues
McKinsey considers the value of generative AI in the pharma industry
Organon explores the impact of innovations in contraception and how this can
reduce unintended pregnancy rates
InnoScot Health discusses the way forward in closing the gender health gap
Page 22 – An overview of women’s health in 2024
Pharmafocus considers the current landscape of women’s health, covering recent debates and ongoing issues within the reproductive health sphere

Top news

Page 4 – Roche announces new data for continuous glucose monitoring system
Page 6 – GSK announces data from phase 3 trial for Jemperli combinations for endometrial cancer 
Page 10 – J&J MedTech and NVIDIA to collaborate for surgical AI 
Page 12 – Ambrx Biopharma acquired by J&J for approximately $2bn

Our Team

Executive Director
PMGroup Worldwide Ltd
Karl Equi
Group Managing Editor
Iona Everson
Editorial Assistants
Betsy Goodfellow
betsy@pharmafile.com

Sales Manager
Eliot Haynes
Design & Layout
Peter May
Pharmafocus is published by:
Samedan Ltd
Suite E, 11 Bell Yard Mews,
175 Bermondsey Street,
London, SE1 3TN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Subscriptions & Data Management
Curwood CMS Tel: 01580 883840
ISSN: 1465-5403
Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).
All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.
©2024 Samedan Ltd, Pharmaceutical Publishers
The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.